A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Trial details
- Registry ID
- NCT06127043
- Drugs studied
- Rosnilimab
TrialRedline tracks 5 clinical trials sponsored by AnaptysBio, Inc.: 5 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)NCT06127043 | Rosnilimab | Active not recruiting | 2026-01Estimated |
| A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269 | Rosnilimab | Active not recruiting | 2024-11-29Estimated |
| Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic AsthmaNCT03469934 | Etokimab | Completed | 2018-10-30Actual |
| Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut AllergyNCT02920021 | Etokimab | Completed | 2018-03-30Actual |
| This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).NCT05935085 | ANB032 | Terminated | 2024-10-16Actual |
Names as written in the registry records.